Our understanding of COVID-19 vaccinations and their impact on health and mortality has
evolved substantially since the first vaccine rollouts. Published reports from the original …

Long coronavirus disease (COVID) is the development or persistence of symptoms after an
acute SARS-CoV-2 (COVID-19) infection. Fewer patients are developing acute COVID-19 …

While the end of the COVID-19 pandemic was announced earlier in 2023 by WHO, the
currently dominating COVID-19 virus variants, such as the omicron sub-lineages XBB. 1.5 …

Nattokinase, from the Japanese fermented food natto, is a protease with fibrinolytic activity
that can thus degrade conventional blood clots. In some cases, however, including in Long …

The coronavirus SARS-CoV-2 is the causative pathogen of the COVID-19 pandemic that has
been causing global upheaval since 2019. The widespread administration of vaccines has …

Millions worldwide experience post-acute sequelae of COVID-19 (PASC or long COVID),
according to the World Health Organization (WHO), European Union and the UK and US …

Background: Since the onset of widespread COVID-19 vaccination campaigns, there have
been concerns about serious cardiovascular adverse events, including myocarditis …

Abstract A cohort of 30,423 Covid-19 patients treated between March 2020 and December
2021 at the IHU-Méditerranée Infection in Marseille (France) was retrospectively analyzed in …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has transcended its initial …

The global economic impact of acute COVID-19 deaths was initially estimated at $3.7 trillion.
However, Long COVID has shattered this ceiling, only assuming that is developed by 10% of …